Singapore-based life sciences technology conglomerate Esco Group, which recently announced an RMB100 million ($15 million) investment in a new innovation centre in China, plans to raise up to $100 million for a spin-off fund that will invest in life sciences startups, a top executive with the firm told this portal.
End the Year with a Deal You Can’t Miss!
Subscribe now and save 40% on our premium subscription.
Enjoy unlimited access for a full year at just $199 (usual price $339).
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Offer valid for a limited time – don’t wait to unlock the insights that drive deal-making in Asia!
Subscribe nowAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
